Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Onyx spells out layoff policies as staffers brace for post-buyout cuts

Every time a biotech is bought out, there's always one big question on the minds of every rank-and-file employee not in line for a golden handshake: Will I have a job when the dust settles?

Vasella considers his Novartis results worth $78M payout

In an interview with the  Financial Times, Vasella argued that the board's demands for a stringent noncompete clause amounted to "a prohibition to exert my profession."

Novo Nordisk taps new chief for American operations

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Pharma veteran Jeffrey Jonas takes top spot at Sage

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

UPDATED: Ex-Shire exec takes helm at startup Sage Therapeutics

Sage Therapeutics has recruited pharmaceutical veteran Dr. Jeffrey Jonas as CEO in a hiring drive that adds decades of industry experience at the two-year-old startup.

Biotechs crowd list of top growth leaders as Big Pharmas shrink staffs

EP Vantage--an arm of EvaluatePharma--put its analysts to the task of examining employment numbers in the biopharma industry and pinpointed which companies are doing the most hiring and firing. The overall amount of downsizing isn't quite as big as you may have been led to believe.

KaloBios announces retirement of CFO

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Pharma professionals feeling angst, but see a few rays of hope

With the patent cliff continuing to fell blockbusters, with earnings suffering as a result and layoffs and retrenchments often the response, it is no surprise that a little angst shows through in Pharma iQ 's look at the industry, particularly when it comes to job prospects in the next year.

Siemens CEO Peter Löscher ousted amid revenue struggle

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Sanofi swaps leaders at animal health unit Merial

The French drugmaker replaced Jose Barella with Carsten Hellmann, formerly of Chr. Hansen Holding; Barella is leaving to pursue other opportunities.